Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $117.37 USD
Change Today -0.63 / -0.53%
Volume 1.0M
LH On Other Exchanges
Symbol
Exchange
Berlin
As of 4:15 PM 06/3/15 All times are local (Market data is delayed by at least 15 minutes).
text size: T | T
Back to Snapshot
Company Description

Contact Info

358 South Main Street

Burlington, NC 27215

United States

Phone: 336-229-1127

Fax:

Laboratory Corporation of America Holdings and its subsidiaries operate as an independent clinical laboratory company in the United States. The company operates a national network of 39 primary laboratories and approximately 1,750 patient service centers (PSCs) along with a network of branches and STAT laboratories (which are laboratories that have the ability to perform certain core tests and report the results to the physician quickly). The company, through its national network of laboratories, offers a range of clinical laboratory tests that are used by the medical profession in core testing, patient diagnosis, and in the monitoring and treatment of disease. Laboratory Testing Operations and Services Testing Services Core Testing The company offers a range of clinical laboratory tests and procedures. Several of these are used in general patient care by physicians to establish or support a diagnosis, to monitor treatment or medication, or to search for an otherwise undiagnosed condition. The most frequently-requested of these core tests include blood chemistry analyses, urinalyses, blood cell counts, thyroid tests, Pap tests, Hemoglobin A1C, PSA, STD tests (Ct, Ng, Tv, and HIV), HCV tests, microbiology cultures and procedures, and alcohol and other substance-abuse tests. These core procedures are used by physicians in their outpatient office practices. Physicians might elect to send such procedures to an independent laboratory (including hospital laboratories) or they might choose to establish their own laboratory to perform some of the tests. The company performs this group of core tests in each of its primary laboratories. This testing constitutes a majority of the tests performed by the company. The company performs and reports majority core procedures within 24 hours, utilizing various computerized laboratory testing instruments. Specialty Testing The company’s Specialty Testing Group performs esoteric testing, cancer diagnostics, clinical trials central lab services, and other complex procedures. The Specialty Testing Group offers advanced methods and access to scientific expertise in the following disciplines: Anatomic Pathology/Oncology: The company offers advanced tumor tissue analysis, including immunohistochemistry, cancer cytogenetics, and fluorescence in situ hybridization through its DIANON Pathology and Integrated Oncology specialty testing laboratories. Applications for molecular diagnostics continue to increase in oncology for both the analysis of leukemia, as well as the assessment of solid tumors. In cancers, such as colon and lung cancer; and assays, such as K-ras, BRAF, and EGFR mutation analysis are associated with appropriate therapy choices for a given patient (Pharmacogenomics). Cardiovascular Disease: The company's cardiovascular menu includes core cholesterol tests and expanded lipid profiles, as well as a metabolic syndrome profile and tests for thrombosis and stroke. The company also offers complete testing for monitoring disease progression and response to therapy. Coagulation: The company offers a menu of tests for hemostasis and thrombosis, including bleeding profiles and screening tests, profiles for reproductive health, factor analysis, thrombin generation markers, and thrombotic risk evaluation. Diagnostic Genetics: The company offers cytogenetic, molecular cytogenetic, biochemical, and molecular genetic tests. The biochemical genetics offerings include various prenatal screening options, including integrated and sequential prenatal assays and non-invasive prenatal testing for sensitive assessment of Down Syndrome risk. The company has expanded its cytogenetics offerings through the use of whole genome single-nucleotide polymorphism microarray technology, which provides improved detection of subtle chromosomal changes associated with the etiology of mental retardation, developmental delay and autism. The molecular genetics services include multiplex analyses of various disorders, gene sequencing applications for both somatic and germ-line alterations, and whole exome sequencing. Through Integrated Genetics, the company provides the genetic

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
LH:US $117.37 USD -0.63

LH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cerner Corp $67.75 USD +0.61
Hologic Inc $36.43 USD +0.20
PAREXEL International Corp $66.40 USD +0.24
Quest Diagnostics Inc $74.36 USD -0.40
Sonic Healthcare Ltd A$19.59 AUD -0.22
View Industry Companies
 

Industry Analysis

LH

Industry Average

Valuation LH Industry Range
Price/Earnings 26.1x
Price/Sales 1.7x
Price/Book 2.6x
Price/Cash Flow 24.4x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact LABORATORY CRP OF AMER HLDGS, please visit www.labcorp.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.